Skip to main content

Market Overview

Axon Enterprise (NASDAQ:AXON) Press Releases

Thursday, February 25, 2021

Axon (AXON) Reports 2020 Revenue of $681 Million, Up 28%, Raises 2021 Outlook (AXON, Earnings, Press Releases / Thu, 04:01pm)

Thursday, February 11, 2021

Axon to Release Fourth Quarter and Full Year 2020 Earnings on February 25, 2021 (AXON, Press Releases / Thu, 07:30am)

Tuesday, February 09, 2021

Axon and Cellebrite Partner to Help Manage and Safeguard Digital Intelligence (AXON, Press Releases / Tue, 07:30am)
Axon And Cellebrite Partner to Help Manage and Safeguard Digital Intelligence (AXON, News, Contracts, Press Releases / Tue, 07:30am)
Axon and Cellebrite Partner to Help Manage and Safeguard Digital Intelligence (AXON, Press Releases / Tue, 07:30am)

Thursday, February 14, 2019

Axovant Announces Formation of Arvelle Therapeutics and Strategic Transition of Legacy Small Molecule Team Into Newly Formed Company (AXGT, AXON, Press Releases / Thu, 07:00am)

Tuesday, February 12, 2019

Hercules Capital Announces Multiple Outstanding Achievements by Numerous Investment Portfolio Companies (ACRX, ATRS, AXON, HCXY, HCXZ, HTGC, PRTK, VSTM, WMT, Press Releases / Tue, 06:00am)

Thursday, February 07, 2019

Axovant Announces Third Fiscal Quarter 2018 Financial Results and Corporate Updates (AXON, Earnings, Press Releases / Thu, 04:15pm)

Thursday, January 03, 2019

Axovant Announces Presentation at J.P. Morgan Healthcare Conference and Anticipated 2019 Clinical Development Milestones (AXON, News, Press Releases / Thu, 07:00am)

Wednesday, January 02, 2019

Roivant Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference (AXON, MYOV, UROV, Press Releases / Wed, 08:00am)

Wednesday, December 26, 2018

Detailed Research: Economic Perspectives on Canopy Growth, ArQule, MoneyGram International, Teradata, Clovis Oncology, and Axovant Sciences — What Drives Growth in Today's Competitive Landscape (ARQL, AXON, CGC, CLVS, MGI, TDC, Analyst Ratings, Press Releases / Wed, 07:25am)

Wednesday, December 19, 2018

Roivant Sciences and Daiichi Sankyo Enter into Broad Pipeline Partnership (AXON, Press Releases / Wed, 07:00am)

Friday, December 14, 2018

Axovant Sciences Announces Pricing of $30 Million Public Offering of Common Shares (AXON, Press Releases / Fri, 09:00am)

Thursday, December 13, 2018

Monday, December 10, 2018

Axovant Reports Results of Exploratory Phase 2 Clinical Study of Nelotanserin in Lewy Body Dementia Patients Experiencing REM Sleep Behavior Disorder (AXON, Health Care, Press Releases, General / Mon, 07:00am)

Thursday, December 06, 2018

Axovant Announces Feedback From FDA Meeting Regarding AXO-Lenti-PD for Parkinson's Disease and Progress in Ongoing SUNRISE-PD Phase 2 Clinical Trial (AXON, Press Releases / Thu, 07:00am)

Monday, November 26, 2018

Wednesday, November 07, 2018

Axovant Announces Second Fiscal Quarter 2018 Financial Results and Corporate Updates (AXON, Earnings, Press Releases / Wed, 04:05pm)

Thursday, October 25, 2018

Friday, October 19, 2018

New Research: Key Drivers of Growth for Teva Pharmaceutical Industries, Axovant Sciences, SolarEdge Technologies, NantHealth, Kosmos Energy, and Retrophin — Factors of Influence, Major Initiatives and Sustained Production (AXON, KOS, NH, RTRX, SEDG, TEVA, Press Releases / Fri, 08:10am)

Tuesday, October 09, 2018

Axovant Announces Data to be Presented at the Annual Congress of the European Society of Gene and Cell Therapy (AXON, News, Press Releases / Tue, 08:02am)

Thursday, September 20, 2018

Axovant to Present at Two Upcoming Investor Conferences (AXON, News, Health Care, Management, Press Releases / Thu, 06:00am)

Monday, September 17, 2018

Roivant Launches Respivant Sciences to Develop Innovative Therapeutics for Respiratory Diseases (AXON, Press Releases / Mon, 08:00am)

Wednesday, August 29, 2018

Axovant to Present at Upcoming Investor Conferences (AXON, News, Press Releases / Wed, 06:00am)

Tuesday, August 07, 2018

Axovant Announces First Fiscal Quarter 2018 Financial Results and Corporate Update (AXON, Earnings, Press Releases / Tue, 03:05pm)

Sunday, July 08, 2018

Axovant Announces Global Licensing Agreement for AXO-AAV-OPMD Program for Treatment of Oculopharyngeal Muscular Dystrophy and Broader Platform Collaboration with Benitec Biopharma (AXON, Press Releases / Sun, 07:17pm)

Monday, June 18, 2018

Axovant to Present at First Annual Roivant Pipeline Day (AXON, News, Press Releases / Mon, 07:30am)

1	ARKQ, OSK: Cathie Wood Buys The Dip In Workhorse Again
2	BHTG, WKHS: 40 Stocks Moving in Thursday's Pre-Market Session
3	PLUG: PreMarket Prep Stock Of The Day: Plug Power
4	AMC, MRNA: Here's Why Moderna, Plug Power, AMC, GameSt...
5	CCIV, HNHPF: Top 10 Electric Vehicle Stocks You Sh...
6	SINO, LPSN: 33 Stocks Moving in Friday&...
7	GME: Gamestop And High Volati...

1	HITIF, MBII: Cannabis Stock Gainers And Losers From February 26, 2021
2	GME, AMC: Why GameStop Stock Traders Should Beware The 'Law Of Two...
3	TSLA: Why Tesla Is Shifting More EVs To Lithium Iron Phosphate...
4	SKLZ, STPK: Jim Cramer Shares 10 SPACs 'To Die For'
5	WDAY: 4 Workday Analysts Break Down Earnings, Loo...
6	RKT, MS: Rocket Companies 'Firing On All...
7	NVDA, STOR: 'Fast Money Halftime...